Some academic research groups are using antifungal agents in asthma, with some success, Umetsu notes. In the future, he would like to target NKT cells in patients with severe asthma if a successful targeting method could be found.The paper's first author was Lee Albacker, PhD, of the Division of Immunology at Boston Children's Hospital, who worked on the study as a graduate student in the Immunology Program at Harvard University. Coauthors were Vinod Chaudhary, PhD, and Paul Savage, PhD, of Brigham Young University, and Ya-Jen Chang, PhD, Hye Young Kim, PhD, Ya-Ting Chuang, PhD, Muriel Pichavant, PhD, Rosemarie DeKruyff, PhD, of Boston Children's Hospital.
Fungal Infections Can Trigger And Exacerbate Asthma
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts